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Abstract: 
 
Background: Invasive fungal diseases (IFDs) are opportunistic infections associated with significant mortality 
in paediatric patients, especially in those with compromised immune system and neonates with very low birth 
weight (VLBW). The objectives of this study are to determine the prevalence, clinical features and fungi 
isolates of neonatal sepsis in three hospitals in Egypt.  
Methodology: The study is a cross sectional survey of 176 neonates with clinical sepsis admitted to the 
neonatal intensive care units (NICU) of the three hospitals over a period of one year (February 2015 to January 
2016). A minimum of two blood samples (collected within 24 hours) from each neonate were cultured for 
bacteria in automated BacT/AlerT and conventional culture bottles, while Saboraud-Brain Heart Infusion broth 
was inoculated for fungi culture. Positive growths from the broth were sub-cultured on Sabouraud Dextrose 
Agar (SDA) plates for aerobic incubation at 25oC and 37oC for 2 weeks. Identification of fungi colonies on SDA 
was by conventional morphology and confirmation on chromogenic agar media. Phylogenetic analysis of 
representative fungi isolates was done by partial nucleotide sequencing of D1-D2 domain of the large subunit 
rRNA gene. 
Results: Of the 176 neonates, blood culture was positive for pathogens in 55 (31.3 %) samples and fungi 
were isolated in 26 (14.8 %); yeast (25) and mould (1). The commonly isolated yeasts were Candida albicans, 
Candida tropicalis, and Candida krusei representing 34.6%, 30.8% and 23.1%, respectively of the total fungi 
isolated. The phylogenetic analysis in comparison to Genbank data showed defined clades for Candida 
tropicalis, Candida parapsilosis, Candida albicans and Pichia kudriavzevii  
Conclusion: This current study highlights the changing pattern of neonatal infections in Egypt caused by 
Candida, with increasing incidence of infections caused by non-albicans Candida species.  
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Abstrait: 
 
Contexte: Les maladies fongiques invasives (IFD) sont des infections opportunistes associées à une mortalité 
significative chez les patients pédiatriques, en particulier ceux dont le système immunitaire est compromis et 
les nouveau-nés de très faible poids à la naissance (VLBW). Les objectifs de cette étude sont de déterminer la 
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prévalence, les caractéristiques cliniques et les isolements fongiques de la sepsie néonatale dans trois hôpitaux 
en Égypte. 
Méthodologie: L'étude est une enquête transversale menée auprès de 176 nouveau-nés présentant une 
septicémie clinique et admis dans les unités de soins intensifs néonatals des trois hôpitaux sur une période 
d'un an (de février 2015 à janvier 2016). Un minimum de deux échantillons de sang (recueillis dans les 24 
heures) de chaque nouveau-né ont été cultivés pour la bactérie dans des flacons de culture automatisés 
BacT/AlerT et conventionnels, tandis que le bouillon Saboraud-Brain Heart Infusion a été inoculé pour la culture 
de champignons. Les croissances positives du bouillon ont été sous-cultivées sur des plaques de gélose 
Sabouraud Dextrose Agar (SDA) pour une incubation aérobie à 25°C et à 37°C pendant 2 semaines. 
L'identification des colonies de champignons sur la SDA a été réalisée par la morphologie conventionnelle et 
confirmée sur un milieu chromogène en gélose. L'analyse phylogénétique d'isolats de champignons 
représentatifs a été réalisée par séquençage partiel de nucléotides du domaine D1-D2 du gène de l'ARNr de 
grande sous-unité. 
Résultats: Sur les 176 nouveau-nés, la culture de sang était positive pour les agents pathogènes dans 55 
échantillons (31,3%) et les champignons ont été isolés dans 26 (14,8%); levure (25) et moisissure (1). Les 
levures communément isolées étaient Candida albicans, Candida tropicalis et Candida krusei, représentant 
respectivement 34,6%, 30,8% et 23,1% du total des champignons isolés. L'analyse phylogénétique comparée 
aux données de Genbank a montré des clades définis pour Candida tropicalis, Candida parapsilosis, Candida 
albicans et Pichia kudriavzevii 
Conclusion: La présente étude met en évidence l'évolution du schéma des infections néonatales causées par 
Candida en Égypte, avec une incidence croissante des infections causées par des espèces de Candida non 
albicans. 
 
Mots-clés: infection fongique, néonatale, facteurs de risque, PCR, levure     
          
Introduction:  
  
 Generally, neonatal infections 
continue to be an important cause of 
morbidity and mortality worldwide. This is 
due to lack of adequate preventive and 
therapeutic strategies in low income settings 
and increased survival of preterm and low 
weight newborns with lengthy stays in 
intensive care units (NICUs) in high income 
countries (1).  
 Neonatal sepsis refers to infection in 
newborn less than 28 days old with presence 
of microorganisms (bacteria or fungi) in the 
blood stream in the setting of fever. Preterm 
babies are more commonly affected than 
term babies (2). Two types of neonatal 
sepsis can be defined according to time and 
mode of infection; early onset sepsis (EOS) 
results from maternal intrapartum trans- 
mission of invasive organisms and can be 
diagnosed when there is positive microbial 
cultures during the first 7 days of life or 
during the first 72 hours of life in case of 
very low birth weight (VLBW) infants (3). 
Late-onset sepsis (LOS) referred to infection 
in blood and cerebrospinal fluid occurring 
after 7 days of delivery, which occurs from 
postnatal acquisition (nosocomial or 
community sources) of pathogens (4).  
 It has been reported that the 
incidence of sepsis during the neonatal 
period is higher than any other period of life 
and varies from one place to another (5), 
and from nursery to nursery depending on 
predisposing factors to infections (6, 7). 
Several predisposing factors for fungal 
infections have been identified, some of 
which are related to host factor and others to 
prolonged hospitalization. Innate charact- 
eristics of preterm infants  that  predispose  
 
them to invasive fungal infections include 
relative immunodeficiency resulting from 
decreased number of T-cells and neutrophils, 
immature skin structure, disruption of 
cutaneous barriers, prolonged use of 
antimicrobials, indwelling central venous 
catheters, hyper alimentation, incubation, 
steroids and other uncommon risk factors 
(8). 
 Candida species are important 
hospital acquired pathogens in infants 
admitted to the neonatal intensive care units 
(NICU). In VLBW infants (birth weight less 
than 1500g), Candida albicans is the third 
most common cause of neonatal LOS, which 
occurs after the first 72 hours of life (9). 
Candida albicans represents 60% of neonatal 
fungi infections (10, 11) but non–albicans 
Candida species are also associated with 
neonatal infections and includes Candida 
tropicalis, Candida parapsilosis, Candida krusi 
and Candida glabrata, which are considered 
emerging pathogens (12). 
 The symptoms and signs of neonatal 
sepsis are subtle and overlap with other life 
threatening infectious diseases, thereby 
making early diagnosis difficult (13, 14). 
Blood culture remains the gold standard for 
definitive diagnosis of neonatal sepsis (15). 
Mortality from invasive candidiasis (IC) is 
influenced by variables such as drugs, 
timing, and duration of treatment. Prompt 
treatment and appropriate dosing for 
neonatal IC are important strategies to halt 
progression of disease. The objectives of this 
study are to determine the prevalence of 
fungal neonatal sepsis, characterize the 
aetiological agents and compare the pattern 
with that of our previous study conducted 
over a decade ago.      
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Materials and method: 
 
Study design and setting 
 This was a cross sectional study 
conducted in neonatal intensive care units 
(NICUs) of three Egyptian hospitals; Al-Azhar 
University Hospital, Ain-Shams University 
Hospital and Wadi El-Neel Hospital, between 
February 2015 and January 2016.  
 
Subjects 
 A total of 176 neonates and infants 
less than 6 months of age with clinical sepsis 
admitted to the hospitals during the period of 
study were recruited for the study. Full 
clinical history and physical examination were 
conducted on each subject and data such as 
gestational age, birth weight, mode of 
delivery, and risk factors for sepsis were 
collected into a design form.  
 
Specimen culture and microbial isolation 
 A minimum of two blood samples 
(collected within 24 hours) from each 
neonate were inoculated into BacT/Alert 
bottles for incubation in automated bacteria 
BacT/Alert blood culture machine (BioMérieux 
France) or into Thioglycollate broths for 
conventional aerobic and anaerobic bacteria 
incubation for 14 days. For fungi isolation, 
blood samples were inoculated into 
Saboraud-Brain Heart Infusion broth and 
positive growth sub-cultured on Saboraud 
Dextrose Agar (SDA) plates for aerobic 
incubation at 25C and 37C for two weeks.  
 
Biochemical identification of fungi isolates 
 For mould, identification was carried 
out on the basis of macroscopic and 
microscopic morphology using the universal 
mycology manual (16). Identification of yeast 
species was carried out according to 
macroscopic characteristics on Wickerham 
agar medium, color production on 
chromogenic agar media (Sigma Chemicals, 
USA), germ tube test, chlamydospores 
formation, and carbohydrates fermentation 
and assimilation (17).  
 
Partial sequencing and phylogenetic analysis 
of fungi isolates  
 DNA was extracted using the protocol 
of GeneJET™ genomic DNA purification kit 
(Thermo #k0721). PCR was carried out using 
Maxima Hot Start PCR Master Mix (Thermo, 
#k1061) with amplification of the divergent 
domain at the 5’ end of the large subunit 
(LSU) rRNA gene using primers; NL-1 (5'-
GCATATCAATAAGCGGAGGAAAAG-3') and NL-
4 (5'-GGTCCGTGTTTCAAGACGG-3'). The PCR 
conditions set were 35 cycles of initial 
denaturation at 94oC for 3 min followed by 
denaturation at 94°C for 1 min, annealing at 
50°C for 2 min, and extension at 74°C for 
1.5 min, with a final extension at 74oC for 5 
min. The PCR product was purified using 
GeneJET™ PCR purification Kit (Thermo, 
k0701), and stored at -20°C prior to 
sequencing.     
 The PCR products of five repre- 
sentative isolates were sequenced on GATC 
Company using ABI 3730xl DNA sequencer 
with the forward and reverse primers that 
target the D1-D2 domain of the large subunit 
rRNA gene. The forward and reverse DNA 
sequence reads for each isolate were 
assembled using codon code aligner software 
and submitted to Genbank with assigned 
accession numbers.  
 A phylogram was constructed for the 
5 clinical isolates and their closely related 
strains according to Genbank data based on 
nucleotide divergence in the D1-D2 domain. 
The evolutionary history was inferred using 
the Neighbor-Joining method (18), and the 
percentage of replicate trees in which the 
associated taxa clustered together in the 
bootstrap test (100 replicates) was shown 
next to the branches (19). The tree was 
drawn to scale with branch lengths in the 
same units as those of the evolutionary 
distances used to infer the phylogenetic tree. 
 The evolutionary distances were 
computed using the number of differences 
method (20) and were in the units of the 
number of base differences per sequence. 
The analysis involved 56 nucleotide 
sequences. All ambiguous positions were 
removed for each sequence pair (pairwise 
deletion option). There were a total of 594 
positions in the final dataset. Evolutionary 
analyses were conducted in MEGA X software 
(21). 
 
Statistical analysis  
 Data were analyzed using the 
Statistical Package for the Social Sciences 
(SPSS) version 20.0. Quantitative data were 
expressed as mean ± standard deviation 
(SD) while qualitative data were expressed 
as frequency and percentages. The Chi-
square (X2) test was used to compare 
proportions between two qualitative para- 
meters. The confidence interval was set to 
95% and the accepted margin of error was 
set to 5%. The significance of probability (p 
value) was evaluated as follow; p<0.05 was 
considered significant, p<0.001 was consi- 
dered highly significant, and p>0.05 was 
considered not significant. 
 
Ethical issues 
 The ethical committees of the 
participating hospitals approved the study. 
All patients' information and test results were 
kept confidential. 
 





 A total of 176 neonates and infants 
less than 6 months old with clinical sepsis 
were enrolled, 97 males and 79 females (M: 
F ratio of 1.2). The age range of subjects is 
1-210 days with mean age of 39.7 days 
(Table 1). Blood culture was positive for 
pathogens in 55 subjects (31.3%) and for 
fungi in 26 (14.7%), with 21.5% in females, 
which was significantly higher than 9.3% in 
males (p=0.0391).   
 Twenty one (18.4%) of the 114 early 
onset cases had fungi isolated compared to 5 
of 62 (8.1%) late onset cases but there was 
no significant difference between the two 
cases (p=0.1037). Twenty three of 136 
(16.9%) LBW babies had fungi sepsis 
compared to 3 of 40 (7.5%) NBW babies but 
the difference was not significant (p=0.220). 
Nine of 87 (10.3%) babies who had normal 
vaginal birth had fungi sepsis while 17 of 89 
(19.1%) babies with cesarean section (CS) 
birth had fungi sepsis but no significant 
difference was observed (p=0.1543).    
 The frequency of isolation of the 
fungi species is shown in Table 2 with 24 
isolates being Candida species, one isolate 
was Pichia (yeast) and one isolate was a 
mould (Penicillium). Out of the 24 Candida 
species, non-albicans species accounted for 
15 (62.5%). However the most frequent 
species in descending order were C. albicans 
(n=9, 34.6%), C. tropicalis (n=8, 30.8%) 
and C. krusei (n=6, 23.1%).   
 The Phylogenetic tree (Fig 1) shows 
selected 5 pathogenic yeast isolates and their 
closely related strains according to Genbank 
data. The phylogenetic tree showed defined 
clades for C. tropicalis (isolate 3, MK686027 
and isolate 5, MK686029), C. parapsilosis 
(isolate 4, MK686028), C. albicans (isolate 2, 
MK686026), and P. kudriavzevii (isolate 1, 
MK686025). 
    
 
Table 1: Demographic data and of risk factors for fungi sepsis among neonates and infants in Egypt  
 
Demographic data 
and risk factors  
No of subjects (%) 
(n=176) 
No of subjects with 
fungi isolates (%) 
(n=26) 
X2 95% CI p value 
Gender 
Male 97 (55.1) 9 (9.3) 4.255 0.2034-0.9142 0.0391* 
Female 79 (44.9) 17 (21.5)    
Age (days) 
Mean ± SD 39.7     
Range 1 – 210     
Weight (gm) 
LBW (<2500) 136 (77.3) 23 (16.9) 1.491 0.7136-7.126 0.2220 
NBW (≥2500) 40 (22.7) 3 (7.5)    
Sepsis onset 
EOS 114 (67.8) 21 (18.4) 2.648 0.9056-5.762 0.1037 
LOS 62 (35.3) 5 (8.1)    
Mode of delivery 
NVD 87 (49.4) 9 (10.3) 2.029 0.2553-1.149 0.1543 
CS 89 (50.6) 17 (19.1)    
LBW = low birth weight; NBW = normal birth weight; SD = standard deviation; EOS = early onset; LOS = late onset; NVD = normal vaginal delivery;             
CS = cesarean section; X2 = Chi square; CI = confidence interval; * = significant difference 
   
 
Table 2: Frequency of isolated fungi in neonates and infants with sepsis in Egypt 
 



















Total 26 100 
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 Invasive candidiasis is an emerging 
cause of LOS, especially among infants who 
receive broad-spectrum antimicrobial agents 
(22). Globally, neonatal sepsis is still one of 
the major causes of morbidity and mortality 
in spite of recent advances in health care 
(23). Differing estimates of disease burden 
have been reported from high-income 
countries compared with reports from low-
and-middle-income countries (24). More than 
40% of under-five deaths globally occur in 
the neonatal period resulting in 3.1 million 
newborn deaths each year (25). The majority 
of these deaths usually occur in low income 
countries and almost 1 million of these 
deaths are attributed to infectious causes 
including neonatal sepsis, meningitis and 
pneumonia (26). The prevalence of fungal 
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sepsis in neonates admitted in NICU, ranges 
from 2.6 to 16.7% (27).   
 In the present study, the prevalence 
of 14.7% for fungal sepsis is similar to the 
rates of 11%, 13.6%, 13.9% and 11.97% 
reported by Rani et al., (28), Agarwal et al., 
(29), Chen et al., (30) and Chavhan et al., 
(27) respectively. In a previous study by 
Mokhtar et al., (11), the rate of fungal 
neonatal sepsis reported was 12% of the 
total diagnosed cases while bacterial sepsis 
represented 88%, but in the current study, 
fungal sepsis has increased to 14.7%. 
Advances in neonatal management have led 
to considerable improvement in newborn 
survival (31). 
 The results in this study showed that 
candidal sepsis commonly occurred in low 
weight and preterm neonates, similar results 
were reported in other studies by Schellack 
and Gous (32), Femitha and Joy (33), Kapila 
(34), and Koppad and Prakash (35). Low 
weight and preterm are risk factors for fungal 
sepsis because of immaturity of their 
immune system and invasive intervention. 
Candida species has become the third most 
common cause of late onset sepsis in NICU 
with mortality figures varying between 15 to 
59% (36).     
 The present study shows the 
changing pattern of candidal species (from 
the last decade) among neonatal fungal 
sepsis with increasing prevalence of non-
albicans Candida species which in this study 
constituted 62.5% of the 24 Candida isolates. 
These findings are consistent with other 
recent studies by Kapila (34), Koppad (35) 
and Chavhan (27) which reported prevalence 
rates of 86.4%, 71% and 65% respectively, 
for non-albicans Candida species. Although 
initial reports indicated that most cases were 
due to C. albicans, more recent studies 
showed the emergence of the non-albicans 
C. parapsilosis, by 54% and 30% in the 
study by Ballot et al., (37) and 30% in 
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